0DOL.L
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofront...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2023-04-21
Stock Exchange
LSE
Ticker
0DOL.L
According to Biofrontera AG’s latest financial reports and current stock price. The company's current PE Ratio is 4.37. This represents a change of -978.99% compared to the average of -0.50 of the last 4 quarters.
The mean historical PE Ratio of Biofrontera AG over the last ten years is -7.30. The current 4.37 PE Ratio has changed -6093.92% with respect to the historical average. Over the past ten years (40 quarters), 0DOL.L's PE Ratio was at its highest in in the March 2022 quarter at 2.56. The PE Ratio was at its lowest in in the December 2020 quarter at -47.42.
Average
-7.30
Median
-4.03
Minimum
-30.29
Maximum
-0.21
Discovering the peaks and valleys of Biofrontera AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 788.07%
Maximum Annual PE Ratio = -0.21
Minimum Annual Increase = -99.30%
Minimum Annual PE Ratio = -30.29
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.34 | 59.13% |
| 2023 | -0.21 | -99.30% |
| 2022 | -30.29 | 788.07% |
| 2021 | -3.41 | -26.75% |
| 2020 | -4.66 | -4.49% |
The current PE Ratio of Biofrontera AG (0DOL.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.28
5-year avg
-7.78
10-year avg
-7.30
Biofrontera AG’s PE Ratio is greater than Oxurion N.V. (0.03), greater than Poxel S.A. (-0.26), greater than MDxHealth S.A. (-4.65), greater than Medigene AG (-0.10), greater than PHAXIAM Therapeutics S.A. (-0.02), greater than European Medical Solutions (0.07),
| Company | PE Ratio | Market cap |
|---|---|---|
| 0.03 | N/A | |
| -0.26 | N/A | |
| -4.65 | N/A | |
| -0.10 | N/A | |
| -0.02 | N/A | |
| 0.07 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biofrontera AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biofrontera AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biofrontera AG's PE Ratio?
How is the PE Ratio calculated for Biofrontera AG (0DOL.L)?
What is the highest PE Ratio for Biofrontera AG (0DOL.L)?
What is the 3-year average PE Ratio for Biofrontera AG (0DOL.L)?
What is the 5-year average PE Ratio for Biofrontera AG (0DOL.L)?
How does the current PE Ratio for Biofrontera AG (0DOL.L) compare to its historical average?